55.86
Real-Time Quote
 +1.45 / +2.66%
Today’s Change
45.50
Today|||52-Week Range
60.02
+5.78%
Year-to-Date
Notable Analyst Rating Changes 10/21: (GPOR) (ILMN) (POST) Upgraded; (ABBV) (IBM) (BH...
10:40am / Investing Channel
Benzinga's M&A Chatter for Thursday October 16, 2014
Oct 17 / Benzinga
#PreMarket Primer: Tuesday, October 21: China's Third Quarter Growth Disappoints
8:59am / Benzinga
AbbVie Kills Shire Merger, But Door Opens for Bristol-Myers Squibb?
Oct 16 / TheStreet.com
3 Drugs Critical to Johnson & Johnson's Future
8:27am / MotleyFool.com
Some inversion deals may survive tax changes
Oct 16 / FT.com
European Stocks Rise as Corporate Earnings Overshadow Macro Concerns
6:34am / TheStreet.com
Shire (SHPG) Shares Crash on Concerns Over AbbVie Buyout - Analyst Blog
Oct 16 / Zacks.com
Must Watch Stocks For October 21, 2014
5:24am / Benzinga
Run for Shelter in Community Banks
Oct 16 / TheStreet.com
AbbVie Unveils $5 Billion Buyback; Blames U.S. For Failed Inversion
Oct 20 / Benzinga
Benzinga's Volume Movers
Oct 16 / Benzinga
Benzinga's M&A Chatter for Monday October 20, 2014
Oct 20 / Benzinga
Deal doers slam the brakes on
Oct 16 / FT.com
Announcement Of Termination Of Proposed AbbVie And Shire Transaction
Oct 20 / Benzinga
How Will AbbVie (ABBV) Stock React Today to Abandoned Shire Deal?
Oct 16 / TheStreet.com
AbbVie hits Treasury as Shire deal dies
Oct 20 / FT.com
AbbVie Abandons Shire Takeover Plans as Tax Benefits Recede
Oct 16 / TheStreet.com
Enanta Pharma Reports Update on Collaboration Deal with AbbVie: Will Not Exercise Opt...
Oct 20 / Benzinga
3 Reasons AbbVie's Stock Could Rise
Oct 16 / MotleyFool.com
Will Abbott Labs (ABT) Miss on Earnings This Quarter? - Analyst Blog
Oct 20 / Zacks.com
October 16 Premarket Briefing: 10 Things You Should Know
Oct 16 / TheStreet.com
3 Drugs Stocks Pushing Industry Growth
Oct 20 / TheStreet.com
European Stocks Continue Their Slide Lower; Shire Extends Losses
Oct 16 / TheStreet.com
3 Stocks I'll Buy if the Market Crashes
Oct 20 / MotleyFool.com
Stocks: 5 things to know before the open
Oct 16 / CNNMoney.com
Cramer Reviews His Top 10 List for a Market Recovery: Boxes Checked!
Oct 20 / TheStreet.com
Jim Cramer on the Stock Market Selloff: We Aren't Done Yet
Oct 16 / TheStreet.com
First Detailed Look at Celgene Crohn's Disease Pill Impresses
Oct 20 / TheStreet.com
AbbVie drops proposed $54bn Shire deal
Oct 16 / FT.com
What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock
Oct 20 / MotleyFool.com
CNBC's Stock Pops & Drops From October 15: Twitter, Gogo And GoPro
Oct 15 / Benzinga
Benzinga's Weekend M&A Chatter
Oct 19 / Benzinga
Benzinga's M&A Chatter for Wednesday October 15, 2014
Oct 15 / Benzinga
Long-term reforms of US tax system required to stop 'deserters'
Oct 19 / FT.com
 $55 billion deal halted by tax dodge crackdown
Oct 15 / CNNMoney.com
M&A deal failure at highest since 2008
Oct 19 / FT.com
Hedge funds face their worst year since 2011
Oct 15 / FT.com
We May Have an Investable Bottom; Smoke Always Clears: Jim Cramer's Best Blogs
Oct 18 / TheStreet.com
Jim Cramer's 'Mad Money' Recap: More Nails in the Market's Coffin
Oct 15 / TheStreet.com
Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year?
Oct 18 / MotleyFool.com
Markets Rebound After Getting Crushed Intraday, Still Close Lower
Oct 15 / Benzinga
Infinity Pharmaceuticals' Duvelisib Fails in Mid-Stage Study - Analyst Blog
Oct 17 / Zacks.com
AbbVie Reconsiders Shire Acquisition Due to New Tax Rules - Analyst Blog
Oct 15 / Zacks.com
Pfizer's AstraZeneca pursuit knocked by Shire deal collapse
Oct 17 / FT.com
KeyCorp Falls On Downbeat Results; Penford Shares Climb
Oct 15 / Benzinga
Gilead's Harvoni Receives Notice of Compliance from Canada - Analyst Blog
Oct 17 / Zacks.com
We Aren't Done Yet
Oct 15 / TheStreet.com
Boxes: Checked!
Oct 17 / TheStreet.com
Why Jim Cramer Tells Investors to Watch Ebola, Earnings and Europe
Oct 15 / TheStreet.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.